"HM Madrid es un hospital médico-quirúrgico ubicado en el centro de Madrid que cuenta, además, con dos policlínicos de consultas externas, una Clínica Universitaria Odontológica, un Gimnasio de Rehabilitación y Fisioterapia y un servicio de Podología. Dispone de todas las especialidades médicas y quirúrgicas de adultos además de Urgencias las 24 horas. El Servicio de Diagnóstico por Imagen de HM Madrid está dotado de modernas instalaciones de radiología convencional, mamógrafo digital, ecografía, TAC multicorte (de 32 detectores), resonancia magnética (RM) cerrada de alto campo (de 1,5 Teslas) y RM abierta (de 0,4 Teslas)."

During the past decade, Hospital Universitario conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario" #1 sponsor was "PETHEMA Foundation" with 3 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Cortice Biosciences, Inc." with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Hospital Universitario Madrid Sanchinarro" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario" #1 collaborator was "AstraZeneca UK Limited" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Janssen-Cilag Ltd." with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "TFS Trial Form Support" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario" are "Breast Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Lymphoblastic Leukemia Ph Positive" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Hospital Universitario" in a lesser frequency.

Most popular intervention types in "Hospital Universitario" are "Drug" (10 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "Placebo" (2 trials), "Bevacizumab,Trastuzumab,Paclitaxel,Cyclophosphamide,Myocet" (1 trials), "BuMA Supreme Biodegradable drug coating coronary stent system" (1 trials) and "Carboplatin and Etoposide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Universitario, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".